Brokerages Set United Therapeutics Co. (NASDAQ:UTHR) PT at $312.22

Shares of United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) have been given an average recommendation of “Moderate Buy” by the ten research firms that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and nine have given a buy recommendation to the company. […]

Leave a Reply

Your email address will not be published.

Previous post Riskified Ltd. (NYSE:RSKD) Receives $6.63 Consensus Price Target from Analysts
Next post Zagato’s Cars are Works of Stunning Automotive Art